Press Release: Allegro Diagnostics : Allegro Diagnostics Confirms Clinical Validation of BronchoGen™ Genomic Test for Improved Diagnosis of Lung Cancer in AEGIS-2 Clinical Trial

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics announced the AEGIS-2 clinical trial has met its primary endpoint. Its BronchoGen genomic test improves the accuracy of lung cancer diagnosis in combination with bronchoscopy.